Thor Medical ASA (TRMEDO)

Overview

Thor Medical ASA is a prominent Norwegian company specializing in the production and supply of alpha-particle emitters used for cancer therapy. Established in 2017, the company is headquartered in Oslo, Norway, and aims to advance cancer treatment methodologies through its innovative offerings. With a dedicated focus on harnessing the power of alpha-particle emitters, Thor Medical ASA plays a crucial role in the evolving landscape of cancer therapy, striving to improve patient outcomes and enhance therapeutic effectiveness.

Products and Services

• Alpha-Particle Emitters

  Thor Medical ASA specializes in the development and supply of cutting-edge alpha-particle emitters. These isotopes are utilized in targeted radiotherapy, providing an effective approach to treating various forms of cancer. The unique properties of alpha particles allow for precise targeting of tumor cells while minimizing damage to surrounding healthy tissues.

• Research and Development

  The company is committed to ongoing research and development efforts aimed at enhancing the efficacy and safety of its alpha-particle emitters. Thor Medical ASA collaborates with leading research institutions and medical professionals to explore new applications and optimize existing therapies.

• Consultation Services

  Thor Medical ASA offers expert consultation services to healthcare providers and research organizations interested in implementing alpha-particle emitter therapies. These services include advice on treatment protocols, dosage calculations, and integration into existing therapeutic frameworks, ensuring effective and safe use of their products.

• Training and Support

  To empower healthcare professionals in the use of their products, Thor Medical ASA provides comprehensive training and support programs. These programs cover the handling, application, and safety protocols associated with alpha-particle emitters, equipping practitioners with essential knowledge and skills.